Abstract
US Real-world Effectiveness of Quarterly and Monthly Fremanezumab for Reducing Migraine Days and Headache Days in Adult Patients With Migraine (4191)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have